Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
Tumori|June 30, 2026
Challenging the cornerstone: Toward risk-adapted follow-up in early breast cancerCatia Angiolini, Antonella Ferro, Luca MoscettiBreast Cancer (Dove Medical Press)|March 20, 2018
Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancerMarta Venturelli, Giorgia Guaitoli, Claudia Omarini, et al.Tumori|April 8, 2026
Ten tips to reduce gaps in daily oncology practiceLuca Moscetti, Antonella Ferro, Catia Angiolini, et al.Cancer Management and Research|February 3, 2018
Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are goingClaudia Omarini, Giorgia Guaitoli, Stefania Pipitone, et al.Journal of Cancer Research and Clinical Oncology|September 27, 2005
Impact of gefitinib ('Iressa') treatment on the quality of life of patients with advanced non-small-cell lung cancerAlain Gelibter, Anna Ceribelli, Camillo F Pollera, et al.International Journal of Molecular Sciences|July 9, 2022
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic ReviewFabio Canino, Federico Piacentini, Claudia Omarini, et al.Molecular and Clinical Oncology|May 27, 2020
Male mammary myofibroblastoma: Two case reports and brief review of literatureMarta Venturelli, Angela Toss, Laura Cortesi, et al.Clinical Breast Cancer|March 5, 2022
Ocular Toxicity in Breast Cancer Management: Manual for The OncologistFabio Canino, Claudia Omarini, Krisida Cerma, et al.Journal of Chemotherapy (Florence, Italy)|May 21, 2013
Epirubicin and docetaxel as first-line treatment for hormonal receptor positive metastatic breast cancer: the predictive value of luminal subtype: a retrospective cohort analysisFabrizio Nelli, Guido Natoli, Luca Moscetti, et al.Tumori|June 15, 2007
Induction therapy with paclitaxel and carboplatin followed by hyperfractionated radiotherapy plus weekly concurrent chemotherapy and subsequent consolidation therapy in unresectable locally advanced non-small-cell lung cancerEnrico Cortesi, Luca Moscetti, Fabrizio Nelli, et al.Pageof 10